β-Lactam Pharmacokinetic/Pharmacodynamic Target Attainment in Intensive Care Unit Patients: A Prospective, Observational, Cohort Study
Romain Guilhaumou(Hôpital de la Timone), Lionel Velly(Centre National de la Recherche Scientifique), Marc Garnier(Sorbonne Université), Djamel Mokart(Inserm), Pierre Simeone, Constance Chevrier(Inserm), David Lagier(Inserm), Nathan Julian(Aix-Marseille Université), Élisabeth Jouve(Inserm), Olivier Blin(Inserm), Nicolas Bruder(Aix-Marseille Université), Jean Loup Setti(Aix-Marseille Université), Amélie Marsot(Centre Hospitalier Universitaire Sainte-Justine)
Cited by 26
Related Papers
Critical Care Management of Patients Following Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference
|Neurocritical Care|2011|1.1k
Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial
|The Lancet|2018|395
Diagnosis of severe respiratory infections in immunocompromised patients
|Intensive Care Medicine|2020|340
Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study
|Intensive Care Medicine|2017|318